Serge Belanger
Stock Analyst at Needham
(4.61)
# 203
Out of 5,162 analysts
401
Total ratings
55.59%
Success rate
24.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals | Maintains: Buy | $58 → $80 | $55.23 | +44.85% | 15 | Mar 9, 2026 | |
| CRMD CorMedix | Maintains: Buy | $15 → $14 | $6.45 | +117.05% | 21 | Mar 5, 2026 | |
| LQDA Liquidia | Maintains: Buy | $52 → $54 | $36.61 | +47.52% | 36 | Mar 5, 2026 | |
| OCS Oculis Holding AG | Maintains: Buy | $36 → $40 | $25.43 | +57.29% | 3 | Mar 4, 2026 | |
| ESPR Esperion Therapeutics | Maintains: Buy | $4 → $5 | $2.44 | +104.92% | 21 | Mar 3, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $34 → $30 | $18.18 | +65.02% | 9 | Feb 27, 2026 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $56 → $54 | $34.50 | +56.52% | 28 | Feb 26, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $31 → $36 | $22.75 | +58.24% | 25 | Feb 26, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $25 | $17.13 | +45.94% | 16 | Feb 26, 2026 | |
| CYTK Cytokinetics | Maintains: Buy | $84 → $85 | $60.06 | +41.54% | 27 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.76 | +105.48% | 7 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $48 | $28.62 | +67.71% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $28.68 | +46.44% | 20 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $35 | $16.94 | +106.61% | 24 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 | $23.27 | +28.92% | 29 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.01 | - | 17 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.22 | +118.98% | 18 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $11.20 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.88 | +240.37% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $11.01 | +99.82% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.11 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.46 | - | 1 | Mar 31, 2022 |
Xenon Pharmaceuticals
Mar 9, 2026
Maintains: Buy
Price Target: $58 → $80
Current: $55.23
Upside: +44.85%
CorMedix
Mar 5, 2026
Maintains: Buy
Price Target: $15 → $14
Current: $6.45
Upside: +117.05%
Liquidia
Mar 5, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $36.61
Upside: +47.52%
Oculis Holding AG
Mar 4, 2026
Maintains: Buy
Price Target: $36 → $40
Current: $25.43
Upside: +57.29%
Esperion Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $2.44
Upside: +104.92%
Amphastar Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $30
Current: $18.18
Upside: +65.02%
Collegium Pharmaceutical
Feb 26, 2026
Maintains: Buy
Price Target: $56 → $54
Current: $34.50
Upside: +56.52%
Arcutis Biotherapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $31 → $36
Current: $22.75
Upside: +58.24%
MoonLake Immunotherapeutics
Feb 26, 2026
Reiterates: Buy
Price Target: $25
Current: $17.13
Upside: +45.94%
Cytokinetics
Feb 25, 2026
Maintains: Buy
Price Target: $84 → $85
Current: $60.06
Upside: +41.54%
Feb 20, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $8.76
Upside: +105.48%
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $48
Current: $28.62
Upside: +67.71%
Feb 4, 2026
Reiterates: Buy
Price Target: $42
Current: $28.68
Upside: +46.44%
Jan 9, 2026
Maintains: Buy
Price Target: $32 → $35
Current: $16.94
Upside: +106.61%
Jan 9, 2026
Maintains: Buy
Price Target: $30
Current: $23.27
Upside: +28.92%
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.01
Upside: -
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.22
Upside: +118.98%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.20
Upside: -
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.88
Upside: +240.37%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $11.01
Upside: +99.82%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.11
Upside: -
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.46
Upside: -